Daily Mail-SR Tablet
By Daily Mail
Rx
10 Tablet SR in a Strip

Composition
Isoxsuprine(40mg)

Manufacturer - Venova Pharmaceuticals Pvt Ltd
P. O. - C - 58, OLD DLF COLONY, SEC-14 GURGAON HARYANA 122001. INDIA

Expires on or after
March, 2027

liver
Limited information is available regarding the use of Daily Mail-SR Tablet in patients with liver disease. It is advisable to seek guidance from your doctor before using this medication if you have any existing liver issues. Consulting with your healthcare provider is crucial to ensure the safe and appropriate use of Daily Mail-SR Tablet in relation to liver health.

kidney
Limited information exists on using Daily Mail-SR Tablet in patients with kidney disease. It is advisable to consult your doctor regarding its safe use with kidney issues.

alcohol
Consult your doctor when consuming alcohol with Daily Mail-SR Tablet.

driving
When taking Daily Mail-SR Tablet, be cautious when driving. It may reduce alertness, impact vision, or cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Daily Mail-SR Tablet is usually safe for use in pregnancy. Animal studies suggest minimal harm to the baby, but human studies are limited.

breastfeeding
Daily Mail-SR Tablet is considered safe to use while breastfeeding. Studies indicate the drug does not transfer to breastmilk in harmful levels, posing no risk to the baby.
Habit Forming | No |
Chemical Class | Phenylpropane Derivative |
Therapeutic Class | GYNAECOLOGICAL |
Action Class | Beta 2 agonist - Uterus |
₹89
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 18-Nov-2024